Chemotherapy of Fungal Diseases -

Chemotherapy of Fungal Diseases

John F. Ryley (Herausgeber)

Buch | Softcover
XXV, 558 Seiten
2011 | 1. Softcover reprint of the original 1st ed. 1990
Springer Berlin (Verlag)
978-3-642-75460-9 (ISBN)
106,99 inkl. MwSt
Fungal diseases have been with us from antiquity; interest in the chemo therapy of fungal disease has exploded in the past decade. To plan and pro duce a book on the topic of antifungal chemotherapy has come as a personal challenge - and something of an eye-opener - towards the end of my re search career. A landmark publication which still merits reading is Antifungal Chemotherapy (John Wiley & Sons, Chichester, UK), edited by David Speller, which appeared in 1980. However, the fact that ketoconazole, the first of the modern, orally active, wide-spectrum antifungals, attracted no more than two sentences in it indicates just how far we have come in the 1980s. A steady stream of original papers and a number of conference proceedings have chronicled this progress in drug research; outstanding among the latter are the proceedings of an international telesymposium, entitled Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, edited by Robert Fromtling (J.R. Prous, Barcelona, 1987) and volume 544 of the Annals of the New York Academy of Sciences, entitled Antifungal Drugs, edited by Vassil St. Georgiev, and containing papers and posters presented at a most enjoyable 3-day conference held at Garden City, New York, in the autumn of 1987.

Section I. Drug Discovery.- 1 Drug Discovery: A Chemist's Approach.- 2 Drug Discovery: A Biochemist's Approach.- 3 Drug Discovery: Nature's Approach.- 4 Screening and Evaluation In Vitro.- 5 Screening And Evaluation In Vivo.- Section II. Drug Development.- 6 Mode Of Action Studies.- 7 Pharmacokinetic Aspects of Antifungal Therapy.- 8 Hepatic and Endocrine Effects of Azole Antifungal Agents.- 9 Structure-Teratogenicity Relationships Among Antifungal Triazoles.- 10 Formulation.- 11 Regulatory Procedures.- 12 Clinical Trials.- Section III. Clinical Usage.- 13 Clinical Usage - A Dermatologist's Viewpoint.- 14 Therapeutic Considerations in Fungal Vaginitis.- 15 An Infectious Disease Specialist's Viewpoint.- 16 Management of Fungal Infections in Patients with Neoplastic Diseases.- 17 Fungal Infections and AIDS.- 18 Older Drugs.- 19 Systemic Azole Antifungal Drugs - Into the 1990s.- 20 Terbinafine.- 21 Amorolfine.- Section IV. Where Next?.- 22 Other Compounds in Development.

Erscheint lt. Verlag 13.12.2011
Reihe/Serie Handbook of Experimental Pharmacology
Co-Autor D. Armstrong, F.T. Boyle, M. Debono, B. Dupont, S.C. Eardley, O.P. Flint, R.S. Gordee, J.R. Graybill, H. Hänel, T.C. Jones, D. Kerridge, A. Lambert, D. Loebenberg, P.A. Pizzo, A. Polak, W. Ritter, M.M. Roberts, W.R. Robertson, J.F. Ryley, H.J. Schmitt, J.D. Sobel, J.J. Stern, A.M. Sugar, M.H. Tarbit, H. Vanden Bossche, V.V. Villars, T.J. Walsh, R.G. Wilson, M. Zaug
Zusatzinfo XXV, 558 p.
Verlagsort Berlin
Sprache englisch
Maße 155 x 235 mm
Gewicht 878 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Schlagworte Chemotherapeutikum • Chemotherapy • Drug • drug discovery • Mykose • Pilzkrankheit • Screening
ISBN-10 3-642-75460-0 / 3642754600
ISBN-13 978-3-642-75460-9 / 9783642754609
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich